Pilot study on the use of ChondroFiller® liquid for osteoarthritis of the knee

meidrix biomedicals GmbH is pleased to announce that the pilot study by Dr. Weninger in Austria has been completed.

The aim of the study was to determine the outcome of intra-articular injections of ChondroFiller® liquid in combination with stem cells in gonarthrosis. Osteoarthritis of the knee is a painful, degenerative disease of the knee joint characterized by the breakdown of articular cartilage.
We are currently waiting for the results of the study to be made available.